Tech Company Financing Transactions
MicrobiotiX Funding Round
MicrobiotiX secured a $14 million Series B funding round on 9/3/2025. Backers included private investors.
Transaction Overview
Company Name
Announced On
9/3/2025
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
IT Mirae Tower, 33, Digital-ro 9-gil, Geumcheon-gu 304, 604, 606
Seoul, 08511
Republic of Korea
Seoul, 08511
Republic of Korea
Phone
Website
Email Address
Overview
MicrobiotiX pioneering biopharmaceutical company addressing the global health crisis of antibiotic-resistant infections, and leading the development of innovative therapeutics for infectious diseases. MicrobiotiX was established to proactively respond to the rapidly growing crisis of antibiotic resistance as a specialized company focused on the development of bacteriophage-based novel therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dongeun Yong
Browse more venture capital transactions:
Prev: 9/3/2025: Reveal HealthTech venture capital transaction
Next: 9/3/2025: Xampla venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs